Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer.

Here, we show metabolic stress results in GD2+ BCSC phenotype in TNBC and glutamine contributes to GD2+ phenotype, and targeting the glutamine transporters could complement conventional chemotherapy in TNBC.